| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |